1 challenge in vaccine advancement is financial: Many of the health conditions most demanding a vaccine, which include HIV, malaria and tuberculosis, exist principally in poor international locations. Pharmaceutical corporations and biotechnology businesses have very little incentive to establish vaccines for these illnesses due to the fact there i